$CLRI
Cleartronic, Inc.

2023 Q1 Form 10-Q Financial Statement

#000109181823000016 Filed on February 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2021 Q4
Revenue $510.7K $506.7K $519.2K
YoY Change 8.51% -2.41% 36.15%
Cost Of Revenue $71.55K $77.49K $92.24K
YoY Change 8.57% -15.99% 52.88%
Gross Profit $439.1K $429.2K $426.9K
YoY Change 8.5% 0.52% 33.0%
Gross Profit Margin 85.99% 84.71% 82.23%
Selling, General & Admin $361.7K $389.7K $316.5K
YoY Change 44.1% 23.15% 24.97%
% of Gross Profit 82.37% 90.81% 74.12%
Research & Development $2.000K $21.82K $49.26K
YoY Change -95.75% -55.71% 59.99%
% of Gross Profit 0.46% 5.08% 11.54%
Depreciation & Amortization $1.282K $1.080K $814.00
YoY Change 33.54% 32.68% 80.49%
% of Gross Profit 0.29% 0.25% 0.19%
Operating Expenses $365.0K $412.6K $366.5K
YoY Change 22.08% 12.57% 28.85%
Operating Profit $74.15K $16.54K $60.42K
YoY Change -29.88% -72.63% 65.34%
Interest Expense $680.00 $550.00 -$170.00
YoY Change -780.0% -423.53%
% of Operating Profit 0.92% 3.33% -0.28%
Other Income/Expense, Net $678.00 $549.00 -$168.00
YoY Change -771.29% -426.79% -84.93%
Pretax Income $74.83K $17.08K $60.25K
YoY Change -29.18% -71.64% 70.07%
Income Tax
% Of Pretax Income
Net Earnings $74.83K $17.08K $60.25K
YoY Change -29.18% -71.64% 70.07%
Net Earnings / Revenue 14.65% 3.37% 11.6%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 228.8M shares 228.1M shares 228.6M shares
Diluted Shares Outstanding 599.5M shares 599.3M shares 599.9M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $385.8K $280.2K $378.1K
YoY Change 0.51% -25.9% 546.97%
Cash & Equivalents $385.7K $280.2K $378.1K
Short-Term Investments
Other Short-Term Assets $33.62K $43.67K $14.02K
YoY Change -6.71% 211.48% -73.95%
Inventory $22.07K $21.10K $21.24K
Prepaid Expenses $20.87K $25.67K
Receivables $531.0K $562.8K $273.4K
Other Receivables $1.350K $670.00 $0.00
Total Short-Term Assets $973.8K $908.4K $686.7K
YoY Change 33.42% 32.27% 121.28%
LONG-TERM ASSETS
Property, Plant & Equipment $17.10K $14.06K $15.64K
YoY Change 16.48% -10.07% 95.93%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $112.3K $67.36K $66.82K
YoY Change 65.19% 0.81% 198.31%
TOTAL ASSETS
Total Short-Term Assets $973.8K $908.4K $686.7K
Total Long-Term Assets $112.3K $67.36K $66.82K
Total Assets $1.086M $975.7K $753.6K
YoY Change 36.13% 29.48% 126.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $79.80K $108.2K $186.4K
YoY Change -47.85% -41.97% -21.86%
Accrued Expenses $23.24K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $937.1K $910.5K $1.001M
YoY Change -0.29% -9.08% 4.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $108.4K $99.57K $144.2K
YoY Change -24.92% -30.95% 614.92%
Total Long-Term Liabilities $108.4K $99.57K $144.2K
YoY Change -24.93% -30.95% 13.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $937.1K $910.5K $1.001M
Total Long-Term Liabilities $108.4K $99.57K $144.2K
Total Liabilities $1.046M $1.010M $1.146M
YoY Change -3.57% -11.83% 5.67%
SHAREHOLDERS EQUITY
Retained Earnings -$15.20M -$15.28M -$15.63M
YoY Change -2.29%
Common Stock $2.288K $2.288K $2.286K
YoY Change 0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.53K -$34.30K -$392.0K
YoY Change
Total Liabilities & Shareholders Equity $1.086M $975.7K $753.6K
YoY Change 36.13% 29.48% 126.46%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2021 Q4
OPERATING ACTIVITIES
Net Income $74.83K $17.08K $60.25K
YoY Change -29.18% -71.64% 70.07%
Depreciation, Depletion And Amortization $1.282K $1.080K $814.00
YoY Change 33.54% 32.68% 80.49%
Cash From Operating Activities $109.9K -$188.0K -$17.85K
YoY Change 1835.04% 953.36% 826.26%
INVESTING ACTIVITIES
Capital Expenditures $4.320K $5.058K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.320K -$5.058K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 109.9K -$188.0K -$17.85K
Cash From Investing Activities -4.320K -$5.058K
Cash From Financing Activities 0.000
Net Change In Cash 105.6K -$188.0K -$22.91K
YoY Change 1758.98% 720.77% 30.58%
FREE CASH FLOW
Cash From Operating Activities $109.9K -$188.0K -$17.85K
Capital Expenditures $4.320K $5.058K
Free Cash Flow $105.6K -$188.0K -$22.91K
YoY Change 1758.98% 720.77% 1088.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
228780695 shares
CY2022Q4 clri Increase Decrease In Due From Related Parties Non Current
IncreaseDecreaseInDueFromRelatedPartiesNonCurrent
usd
CY2022Q4 dei Document Type
DocumentType
10-Q
CY2022Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 dei Entity Registrant Name
EntityRegistrantName
CLEARTRONIC, INC.
CY2022Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2022Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
65-0958798
CY2022Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
28050 US Hwy 19N
CY2022Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Clearwater
CY2022Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33761
CY2022Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Security12b Title
Security12bTitle
Common stock Par Value $0.00001
CY2022Q4 dei Trading Symbol
TradingSymbol
CLRI
CY2022Q4 dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
228780695 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
468167 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
562782 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
538030 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
21097 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
21097 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43665 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53611 usd
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
280153 usd
CY2022Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
666 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
908363 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1080905 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14061 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15142 usd
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
53302 usd
CY2022Q3 us-gaap Due From Related Parties
DueFromRelatedParties
53302 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
53302 usd
CY2022Q3 us-gaap Other Assets
OtherAssets
53302 usd
CY2022Q4 us-gaap Assets
Assets
975726 usd
CY2022Q3 us-gaap Assets
Assets
1149349 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
108149 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
75217 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
802305 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1012211 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
910454 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
1087428 usd
CY2022Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
99567 usd
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
113300 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
99567 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
113300 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1010021 usd
CY2022Q3 us-gaap Liabilities
Liabilities
1200728 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2288 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2281 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240106 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
15240112 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15276764 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15293848 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-34295 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51379 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
975726 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1149349 usd
CY2022Q4 us-gaap Revenues
Revenues
506650 usd
CY2021Q4 us-gaap Revenues
Revenues
519185 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
77491 usd
CY2021Q4 us-gaap Cost Of Revenue
CostOfRevenue
92236 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
429159 usd
CY2021Q4 us-gaap Gross Profit
GrossProfit
426949 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
67831 usd
CY2021Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
188545 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
321898 usd
CY2021Q4 us-gaap Depreciation
Depreciation
814 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
127915 usd
CY2022Q4 us-gaap Depreciation
Depreciation
1080 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21815 usd
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49260 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
412624 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
366534 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
549 usd
CY2021Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-168 usd
CY2022Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
549 usd
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-168 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17084 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
60247 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
17084 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
60247 usd
CY2022Q4 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10344 usd
CY2021Q4 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
10344 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6740 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49903 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2021Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228630043 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228578995 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599331678 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599940630 shares
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
17084 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
60247 usd
CY2022Q4 us-gaap Depreciation
Depreciation
1080 usd
CY2021Q4 us-gaap Depreciation
Depreciation
814 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
24752 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-46867 usd
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6588 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-9280 usd
CY2021Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-33364 usd
CY2021Q4 clri Increase Decrease In Due From Related Parties Non Current
IncreaseDecreaseInDueFromRelatedPartiesNonCurrent
6386 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
32933 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
26406 usd
CY2022Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-223639 usd
CY2021Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-172573 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-188014 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17849 usd
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5058 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5058 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-188014 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-22907 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
468167 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
401001 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
378094 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
666 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-51379 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
280153 usd
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
168 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
690 usd
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
690 usd
CY2022Q4 clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
7 usd
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q3 clri Concentration Risk Percentage
ConcentrationRiskPercentage
0.10 pure
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
17084 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-34295 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-452274 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
60247 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-392027 usd
CY2022Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin:0pt"><b>USE OF ESTIMATES</b></p><p style="margin:0pt"> </p><p style="margin:0pt">In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and operations for the reporting period. <br/></p><p style="margin:0pt">Although these estimates are based on management's knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results. </p><p style="margin:0pt"> </p><p style="margin:0pt">Significant estimates include the assumptions used in valuation of deferred tax assets, estimated useful life of property and equipment, valuation of inventory and allowance for doubtful accounts.</p><p style="margin:0pt"> </p>
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
18000 usd
CY2022Q4 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
25500 usd
CY2022Q3 us-gaap Other Deferred Costs Net
OtherDeferredCostsNet
38250 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25667 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18165 usd
CY2022Q4 clri Amount Of Fdic Insurance Limits
AmountOfFdicInsuranceLimits
15720 usd
CY2022 clri Amount Of Fdic Insurance Limits
AmountOfFdicInsuranceLimits
208135 usd
CY2022Q4 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin:0pt"><b>CONCENTRATION OF CREDIT RISK </b></p><p style="margin:0pt"> </p><p style="margin:0pt">The Company currently maintains cash balances at one FDIC-insured banking institution. Deposits held in non interest-bearing transaction accounts are insured up to a maximum of $250,000 at all FDIC-insured institutions. As of December 31, 2022 and September 30, 2022, the Company had $15,720 and $208,135, respectively, in excess of FDIC insurance limits.</p><p style="margin:0pt"> </p>
CY2021Q4 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10344 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
17084 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21815 usd
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49260 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
60247 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228630043 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228630043 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228578995 shares
CY2022Q4 us-gaap Deferred Subscriber Acquisition Costs Current
DeferredSubscriberAcquisitionCostsCurrent
25500 usd
CY2022Q3 us-gaap Deferred Subscriber Acquisition Costs Current
DeferredSubscriberAcquisitionCostsCurrent
38250 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
901872 usd
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
1125511 usd
CY2022Q4 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
506650 usd
CY2021Q4 us-gaap Regulated Operating Revenue
RegulatedOperatingRevenue
519185 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1125511 usd
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1131796 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
901872 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1125511 usd
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6740 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49903 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6740 usd
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
49903 usd
CY2022Q4 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10344 usd
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
228578995 shares
CY2022Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
370701635 shares
CY2021Q4 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
371361635 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599331678 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
599940630 shares
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2022Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
21097 usd
CY2022Q4 us-gaap Other Inventory
OtherInventory
0 usd
CY2022Q3 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
21097 usd
CY2022Q3 us-gaap Other Inventory
OtherInventory
0 usd
CY2022Q4 us-gaap Advertising Expense
AdvertisingExpense
13149 usd
CY2021Q4 us-gaap Advertising Expense
AdvertisingExpense
5025 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21605 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21605 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7544 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6463 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14061 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15142 usd
CY2022Q4 us-gaap Depreciation
Depreciation
1080 usd
CY2021Q4 us-gaap Depreciation
Depreciation
814 usd
CY2022Q4 us-gaap Temporary Equity Description
TemporaryEquityDescription
There are currently 5 series of preferred stock designated as follows:   ● 1,250,000 shares have been designated as Series A Preferred Stock, 512,996 of which are issued and outstanding;   ● 10 shares have been designated as Series B Preferred Stock, none of which is issued and outstanding;   ● 50,000,000 shares have been designated as Series C Preferred Stock, 3,209,503 of which are issued and outstanding; and   ● 10,000,000 shares have been designated Series D Preferred stock, of which 670,904 are issued and outstanding; and   ● 10,000,000 shares have been designated Series E Preferred stock, of which 3,000,000 are issued and outstanding.  
CY2022Q4 clri Number Of Common Stock Shares Issued From Conversion Of Series C Preferred Stock Converted
NumberOfCommonStockSharesIssuedFromConversionOfSeriesCPreferredStockConverted
661000 shares
CY2022Q4 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2343 usd
CY2021Q4 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
5886 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
666 usd
CY2022Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
1145 sqm
CY2022Q4 clri Monthly Rental Cost
MonthlyRentalCost
2134 usd
CY2022Q4 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2198 usd
CY2021Q4 clri Area Of Leased Facility
AreaOfLeasedFacility
2000 sqft
CY2021Q4 clri Monthly Rental Cost
MonthlyRentalCost
2200 usd
CY2021Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2022-11-30
CY2022Q4 clri Concentration Risk Percentage
ConcentrationRiskPercentage
0.10 pure
CY2022Q4 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
2343 usd
CY2021Q4 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
5886 usd
CY2021Q4 clri Concentration Risk The Hold Percentage
ConcentrationRiskTheHoldPercentage
0.14 pure
CY2022Q4 us-gaap Royalty Expense
RoyaltyExpense
3640 usd
CY2021Q4 us-gaap Royalty Expense
RoyaltyExpense
2953 usd
CY2022Q4 dei Local Phone Number
LocalPhoneNumber
289-7620
CY2022Q4 dei City Area Code
CityAreaCode
813
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228120995 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
228120995 shares
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2021Q4 clri Cancellationof Shares Of Common Stock
CancellationofSharesOfCommonStock
usd
CY2022Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
usd
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001362516
CY2022Q4 dei Entity File Number
EntityFileNumber
000-55329

Files In Submission

Name View Source Status
0001091818-23-000016-index-headers.html Edgar Link pending
0001091818-23-000016-index.html Edgar Link pending
0001091818-23-000016.txt Edgar Link pending
0001091818-23-000016-xbrl.zip Edgar Link pending
clri-20221231.htm.htm Edgar Link pending
clri-20221231.xsd Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
clri-20221231_cal.xml Edgar Link unprocessable
clri-20221231_def.xml Edgar Link unprocessable
clri-20221231_lab.xml Edgar Link unprocessable
clri-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clri-20221231.htm_htm.xml Edgar Link completed
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending